Mixing insulin lispro and ultralente insulin - Reply

被引:1
|
作者
Bolli, GB
Torlone, E
机构
关键词
D O I
10.2337/diacare.20.6.1048a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1048 / 1048
页数:1
相关论文
共 50 条
  • [31] Advantage of insulin lispro in suspected insulin allergy
    Pánczél, P
    Hosszúfalusi, N
    Horváth, MM
    Horváth, A
    [J]. ALLERGY, 2000, 55 (04) : 409 - 410
  • [32] The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph, S
    Burakowska, A
    Woodworth, J
    Evans, M
    Hopkins, D
    Cerimele, B
    Yordy, R
    Amiel, S
    [J]. DIABETES, 1997, 46 : 641 - 641
  • [33] Stability of insulin lispro in insulin infusion systems
    Lougheed, WD
    Zinman, B
    Strack, TR
    Janis, LJ
    Weymouth, AB
    Bernstein, EA
    Korbas, AM
    Frank, BH
    [J]. DIABETES CARE, 1997, 20 (07) : 1061 - 1065
  • [35] Insulin LisPro plus human ultralente provides improved glycemia for eight hours after a meal in IDDM.
    Waters, DL
    Burge, MR
    Schade, DS
    [J]. DIABETES, 1996, 45 : 1062 - 1062
  • [36] PHARMACOKINETICS OF ULTRALENTE (U) INSULIN PREPARATIONS
    REEVES, ML
    SEIGLER, DE
    GOLDBERG, RB
    OLSSON, M
    LOHMAN, VL
    AGRAMONTE, RF
    ASHBY, MH
    [J]. DIABETES, 1986, 35 : A63 - A63
  • [37] Severe insulin resistance treated with insulin lispro
    Henrichs, HR
    Unger, H
    Trautmann, ME
    Pfutzner, A
    [J]. LANCET, 1996, 348 (9036): : 1248 - 1248
  • [38] Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente
    Scholtz, HE
    Becker, RHA
    [J]. DIABETOLOGIA, 2004, 47 : A273 - A273
  • [39] Longterm use of insulin LisPro in intensive insulin therapy
    Pfutzner, A
    Gudat, U
    Trautmann, ME
    [J]. DIABETES, 1996, 45 : 1053 - 1053
  • [40] Reproducability of insulin absorption with insulin lispro and regular insulin during CSII
    Johansson, UB
    Wredling, R
    Lins, PE
    Adamson, U
    [J]. DIABETES, 1998, 47 : A10 - A10